Business
Rockwell Medical Extends Product Purchase Agreement Through 2026 With One of the Largest Dialysis Providers in the United States
WIXOM, Mich., January 05, 2026--Rockwell Medical extends its product purchase agreement with one of the largest dialysis providers in the United States through December 31, 2026.
About this update from Rockwell Medical, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":400,"url":"https://media.zenfs.com/en/business-wire.com/8696f53d0cc1494f71057de0eaf98ad1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/rxNsU2pmZIvnpCwNixmx.w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTcwNTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/8696f53d0cc1494f71057de0eaf98ad1","width":400,"height":400}},"lazy":false},{"type":"text","content":"WIXOM, Mich., January 05, 2026--(BUSINESS WIRE)--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that the Amended and Restated Product Purchase Agreement (the "Amended Agreement") dated September 18, 2023 between the Company and one of the largest dialysis providers in the United States (the "Customer") has been extended through December 31, 2026. As part of the Amended Agreement, product pricing will be increased for the extended term.","length":645,"tagName":"p"},{"type":"text","content":""We are pleased to extend our product purchase agreement with the Customer through the end of this year, and continue to foster our relationship in the hope that we can expand our agreement well beyond 2026," said Mark Strobeck, Ph.D., President and CEO of Rockwell Medical. "We believe this renewal reflects the critical role that our reliable supply chain and high-quality hemodialysis products play in the Customer’s operations. We are committed, and excited for the opportunity, to strengthen our relationship with the Customer and re-establish a more robust, long-term strategic partnership."","length":617,"tagName":"p"},{"type":"text","content":"For more details about this amended and restated products purchase agreement, please reference the Form 8-K filed January 5, 2026.","length":130,"tagName":"p"},{"type":"text","content":"About Rockwell Medical","length":22,"tagName":"p"},{"type":"text","content":"Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Rockwell Medical's mission is...